trial · primary record
Carfilzomib
Colorectal Neoplasms
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 20 |
| Primary completion | 2031-12-31 |
| Primary endpoint | Establish the safety of hepatic artery infusion (HAI) of carfilzomib (CFZ) in participants with liver metastatic disease who were previously treated with HAI pump therapy |
| Registry ID | NCT07715903 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:11.804Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07715903
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.